Cyclophosphamide rob holland
WebA.M. Thornton, in Comprehensive Toxicology, 2010 5.04.8.3 Chemotherapy. Cyclophosphamide is an alkylating cytotoxic drug that is toxic not only to cancer cells but also to proliferating lymphocytes. It is used to treat cancer as well as autoimmune … WebCNS: Headache, dizziness, nervousness, insomnia, peripheral neuropathy, lethargy, poor coordination, seizures. Special Senses: Retinal depigmentation, photophobia, blurred vision, optic neuritis, diplopia, blindness. GI: Abdominal pain, nausea, vomiting, diarrhea, constipation, stomatitis, dry mouth, pancreatitis, increased liver enzymes.
Cyclophosphamide rob holland
Did you know?
Webcyclophosphamide should be administered in the morning. 2.1 Dosing for Malignant Diseases Adults and Pediatric Patients . Intravenous When used as the only oncolytic drug therapy, the initial course of cyclophosphamide for patients with no hematologic … http://www.robholland.com/Nursing/Drug_Guide/data/monographframes/N049.html
Has pronounced immunosuppressive activity and is a highly toxic drug; thus therapeutic effects are usually accompanied by some evidence of toxicity. See more To prevent rejection in homotransplantation; to treat severe rheumatoid arthritis, multiple sclerosis, systemic lupus … See more Cell-cycle-nonspecific alkylating agent chemically related to the nitrogen mustards. Action mechanism unknown but thought to be the result of cross-linkage of DNA strands, … See more As single agent or in combination with other chemotherapeutic agents in treatment of malignant lymphoma, multiple myeloma, leukemias, mycosis fungoides (advanced disease), neuroblastoma, adenocarcinoma of … See more WebPrototype: Cyclophosphamide Pregnancy Category: D Availability 2 mg tablets; 6 mg/mL injection Actions Potent cytotoxic alkylating agent that may be mutagenic and carcinogenic. Cell cycle nonspecific. Reduces total granulocyte mass but has little effect on …
WebFeb 10, 2024 · INTRODUCTION. Cyclophosphamide (CYC), an alkylating agent, is one of the most potent immunosuppressive therapies available. It has been used extensively to treat severe manifestations of a variety of autoimmune and inflammatory diseases. …
http://www.robholland.com/Nursing/Drug_Guide/data/monographframes/F012.html
http://www.robholland.com/Nursing/Drug_Guide/data/monographframes/H022.html chengbenv2.crecsh.comhttp://www.robholland.com/Nursing/Drug_Guide/data/monographframes/A075.html flights europe may have spurredhttp://www.robholland.com/Nursing/Drug_Guide/data/monographframes/F026.html flights europe may spurred new variantWebwith primaquine for eradication of Plasmodium vivaxand Plasmodium malariae. More commonly prescribed than chloroquine for treatment of rheumatoid arthritis and lupus … flights europe may have spurred newWebCyclophosphamide (pronounced sigh-clo-fos-fah-mide) is a type of chemotherapy. It is a treatment for a number of different types of cancer. You can have cyclophosphamide on its own, or in combination with other chemotherapy drugs. How cyclophosphamide works. … cheng beijing oro valley azWebAnticoagulant therapy, pregnancy (category D), especially during first trimester; preexisting endometrial hyperplasia; intramuscular injections if platelets <50,000/mm 3; history of thromboembolic disease; lactation; children. Cautious Use flights europe may spurred spreadWebParkinson's Disease Adult: PO Start with 0.25 mg t.i.d., may titrate up by 0.25 mg/dose t.i.d. qwk to a target dose of 1 mg t.i.d.; if response is still not satisfactory, may continue to increase by 1.5 mg/d q wk to a dose of 9 mg/d, and then by 3 mg/d weekly (max: dose of 24 mg/d) Restless Legs Syndrome Adult: PO Take 0.25 mg 1–3 h before bed x 2 d, … flights europe may have spread